Vimarsana
Biggest News Aggregation in the World

Page 12 - Eric Domingo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Domingo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Domingo Today - Breaking & Trending Today

FDA logs 76,837 adverse events following immunization | Claudeth Mocon-Ciriaco - Vimarsana News

FDA logs 76,837 adverse events following immunization | Claudeth Mocon-Ciriaco

A total of 76,837 or 0.1 percent of Covid-19 vaccinees have experienced Adverse Event Following Immunization (AEFI), Food and Drug Administration director general Eric Domingo said on Thursday.This number of AEFIs, Domingo said was based on the 59,316, 764 administered doses as of November 21."Only 0.005 percent [or 3,874 ]…

DOH eyes Covid-19 vaccination of 13.5M children aged 5-11 - Vimarsana News

DOH eyes Covid-19 vaccination of 13.5M children aged 5-11

(PNA photo by Robert Alfiler) MANILA - The national government is eyeing the vaccination of 13.5 million children aged 5 to 11 against the coronavirus disease 2019 (Covid-19). Health Undersecretary Maria Rosario Vergeire said the country has enough supply of Covid-19 vaccines, with about 40 million doses more expected to arrive by the end of the year. "Lahat ng ating (All of our) priority groups, the rest of the population, are already included in our estimates for the committed doses for 2021. We have enough supplies," she said. However, the vaccination of children remains uncertain...

Related Topics:
Eric DomingoDrug AdministrationHealth Undersecretary Maria Rosario VergeireUndersecretary Maria Rosario VergeireDrug Administration Director General Eric DomingoNa Photo By Robert Alfiler Manila The National Government Is Eyeing Vaccination Of 13 5 Million Children Aged To 11 Against Coronavirus Disease 2019 Covid 19 Health Undersecretary Maria Rosario Vergeire Said Country Has Enough Supply VaccinesIth About 40 Million Doses More Expected To Arrive By The End Of Year Quot Lahat Ng Ating All Our Priority GroupsHe Rest Of The PopulationRe Already Included In Our Estimates For The Committed Doses 2021 We Have Enough SuppliesUot She Said HoweverHe Vaccination Of Children Remains Uncertain Since There Is No Emergency Use Authorization Eua Granted To Any Covid 19 Vaccines That Can Be Administered For Such Age Group So Far Earlier This MonthOod And Drug Administration Director General Eric Domingo Said The Government Is Still Waiting For Pfizer To Submit An Application Eua Its Covid 19 Vaccine As Safe Be Administered Children 5 11 Years Old Ina Palace Briefing ThursdayOmingo Said Chinese Pharmaceutical Firm Sinovac Had Informed Them That It Was Collating Data On The Safety Of Its Covid 19 Vaccine For Use Among Younger Population And Apply An Eua Soon Quot SoI Believe Before The End Of YearE 39 Re Going To Have Vaccines For Children Below 12Uot He Said In OctoberHe Government Started With The Covid 19 Vaccination Of Children Aged 12 To 17 Years Old Using Pfizer And Moderna Vaccines As They Are Only Jabs Approved For Pediatric Inoculation Pna
Only 0.10% of 59 million COVID-19 jabs had adverse events after immunization —FDA - Vimarsana News

Only 0.10% of 59 million COVID-19 jabs had adverse events after immunization —FDA

Fewer than 0.10% out of the 59 million COVID-19 doses administered in the country so far resulted in adverse events following immunization (AEFI), the Food and Drug Administration (FDA) said Thursday.

FDA: COVID-19 vaccine for children aged 11 and below seen by yearend - Vimarsana News

FDA: COVID-19 vaccine for children aged 11 and below seen by yearend

The Food and Drug Administration said Tuesday that COVID-19 vaccine doses for children aged 11 and below might be available in the country by the end of the year.

Merck Pill in Philippines; U.S. to Avoid Lockdowns: Virus Update - Vimarsana News

Merck Pill in Philippines; U.S. to Avoid Lockdowns: Virus Update

Track the global Covid-19 pandemic and vaccination efforts here.